We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STNG:NYSEScorpio Tankers Inc. Analysis

Data as of 2026-05-03 - not real-time

$82.99

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Scorpio Tankers is trading at $82.99, comfortably above its 20‑day ($77.03) and 50‑day ($74.93) moving averages and well above the 200‑day level ($60.56), indicating a strong bullish trend. The MACD histogram remains positive (0.60) and the RSI sits at 68, suggesting momentum is still intact but edging toward overbought territory. Valuation metrics reinforce the case: a trailing P/E of 11.8 is far below the industry average of 22.7, and the stock offers a 2.01% dividend yield with a modest 23% payout ratio, pointing to sustainable cash‑flow coverage. Recent corporate actions—closing a $375 million convertible senior note offering and repurchasing 1.34 million shares at $74.36—have bolstered liquidity while adding a convertible‑debt element to the capital structure.
Looking ahead, analysts project a median price target of $90, implying roughly a 4–5% upside, and the DCF model suggests a fair value near $151, underscoring long‑term upside potential if market sentiment improves. The company’s revenue grew 24% year‑over‑year, margins remain healthy (gross 65%, operating 35%), and free cash flow exceeds $213 million, supporting both dividend continuation and debt service. However, a high 30‑day volatility of 38% and a leveraged balance sheet (debt‑to‑equity ~19) temper enthusiasm, making the stock a compelling but moderately risky play.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above key moving averages and bullish MACD
  • Attractive dividend yield with low payout ratio
  • Recent capital raise and share repurchase improving balance sheet

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to peers (P/E 11.8 vs industry 22.7)
  • Strong revenue growth and solid operating margins
  • Projected upside to median target price of $90

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term DCF fair value suggests significant upside if market sentiment improves
  • High volatility and leverage increase downside risk
  • Convertible note issuance could dilute equity if converted

Key Metrics & Analysis

Financial Health

Revenue Growth23.90%
Profit Margin36.70%
P/E Ratio11.8
ROE11.35%
ROA4.99%
Debt/Equity19.36
P/B Ratio1.2
Op. Cash Flow$491.2M
Free Cash Flow$213.2M
Industry P/E22.7

Technical Analysis

TrendBullish
RSI67.9
Support$72.34
Resistance$83.10
MA 20$77.03
MA 50$74.93
MA 200$60.56
MACDBullish
VolumeDecreasing
Fear & Greed Index91.09

Valuation

Fair Value$150.85
Target Price$86.67
Upside/Downside4.43%
GradeUndervalued
TypeBlend
Dividend Yield2.01%

Risk Assessment

Beta0.25
Volatility38.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.